Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short-term Investments (2017 - 2020)

Historic Short-term Investments for Fortress Biotech (FBIO) over the last 6 years, with Q4 2020 value amounting to $76.8 million.

  • Fortress Biotech's Short-term Investments rose 41200.0% to $76.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $76.8 million, marking a year-over-year increase of 41200.0%. This contributed to the annual value of $76.8 million for FY2020, which is 41200.0% up from last year.
  • As of Q4 2020, Fortress Biotech's Short-term Investments stood at $76.8 million, which was up 41200.0% from $15.0 million recorded in Q4 2019.
  • In the past 5 years, Fortress Biotech's Short-term Investments registered a high of $76.8 million during Q4 2020, and its lowest value of $5.0 million during Q2 2019.
  • Over the past 4 years, Fortress Biotech's median Short-term Investments value was $21.3 million (recorded in 2017), while the average stood at $27.4 million.
  • As far as peak fluctuations go, Fortress Biotech's Short-term Investments tumbled by 8636.83% in 2019, and later soared by 41200.0% in 2020.
  • Quarter analysis of 4 years shows Fortress Biotech's Short-term Investments stood at $36.0 million in 2017, then plummeted by 51.1% to $17.6 million in 2018, then dropped by 14.79% to $15.0 million in 2019, then surged by 412.0% to $76.8 million in 2020.
  • Its Short-term Investments was $76.8 million in Q4 2020, compared to $15.0 million in Q4 2019 and $14.9 million in Q3 2019.